Cytosorbents Corp Contract with Customer, Asset, after Allowance for Credit Loss, Current
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:ContractWithCustomerAssetNetCurrent · last filed 2026-05-13
- 2026-03-31: Contract with Customer, Asset, after Allowance for Credit Loss, Current $6.88M.
- 2025-12-31: Contract with Customer, Asset, after Allowance for Credit Loss, Current $7.13M.
- 2025-09-30: Contract with Customer, Asset, after Allowance for Credit Loss, Current $6.00M.
- 2025-06-30: Contract with Customer, Asset, after Allowance for Credit Loss, Current $6.64M.
| Period end | Contract with Customer, Asset, after Allowance for Credit Loss, Current | Contract with Customer, Asset, after Allowance for Credit Loss, Current as first filed |
|---|---|---|
| 2026-03-31 | $6.88M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $7.13M 10-Q · filed 2026-05-13 | |
| 2025-09-30 | $6.00M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $6.64M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $5.86M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $5.58M 10-K · filed 2026-03-30 | $4.43M 10-K · filed 2025-03-31 |
| 2024-09-30 | $4.85M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $5.91M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $4.97M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $5.30M 10-K · filed 2026-03-30 | $3.85M 10-K · filed 2024-03-15 |
| 2023-09-30 | $4.53M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $4.76M 10-Q · filed 2023-08-01 | |
| 2023-03-31 | $4.01M 10-Q · filed 2023-05-02 | |
| 2023-01-01 | $3.82M 10-K · filed 2025-03-31 | |
| 2022-12-31 | $3.82M 10-K · filed 2024-03-15 | |
| 2022-09-30 | $4.22M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $4.25M 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $3.15M 10-Q · filed 2022-05-03 | |
| 2022-01-01 | $3.00M 10-K · filed 2024-03-15 | |
| 2021-12-31 | $3.00M 10-K · filed 2023-03-09 | |
| 2021-09-30 | $3.42M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $3.56M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $2.76M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $3.00M 10-K · filed 2022-03-10 | |
| 2020-09-30 | $3.18M 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $2.20M 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $2.04M 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $2.25M 10-K · filed 2021-03-09 | |
| 2019-09-30 | $1.91M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $1.81M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $1.95M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $2.40M 10-K · filed 2020-03-05 | |
| 2018-09-30 | $2.38M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $1.44M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $1.25M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $1.27M 10-K · filed 2019-03-07 |